» Articles » PMID: 32355905

CEREBRAL ORGANOIDS AS A MODEL FOR GLIOBLASTOMA MULTIFORME

Overview
Date 2020 May 2
PMID 32355905
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Glioblastoma multiforme (GBM) is a highly lethal and elusive cancer. While many and models have been developed to recapitulate the factors that contribute to its invasive behavior, they suffer from drawbacks related to genetic variability, expense and scope. Technologies utilizing human pluripotent stem cells can now generate organoids which can recapitulate the relative complexity the cytoarchitecture and microenvironment of human brain tissue. In conjunction with protocols which effectively induce GBM tumors within these "cerebral organoids", such approaches represent an unprecedented model to investigate GBM invasion and its effect on the brain ECM. This review focuses on methods of brain organoid development, protocols for inducing GBM, the relevant findings on invasion and microenvironmental changes, and discusses their limitations and potential future direction.

Citing Articles

Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development.

Xiang D, He A, Zhou R, Wang Y, Xiao X, Gong T Theranostics. 2024; 14(8):3300-3316.

PMID: 38855182 PMC: 11155402. DOI: 10.7150/thno.96027.


Biomaterial-based 3D modeling of glioblastoma multiforme.

Ahmed T Cancer Pathog Ther. 2024; 1(3):177-194.

PMID: 38327839 PMC: 10846340. DOI: 10.1016/j.cpt.2023.01.002.


Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.

Chehelgerdi M, Dehkordi F, Chehelgerdi M, Kabiri H, Salehian-Dehkordi H, Abdolvand M Mol Cancer. 2023; 22(1):189.

PMID: 38017433 PMC: 10683363. DOI: 10.1186/s12943-023-01873-0.


Development of glioblastoma organoids and their applications in personalized therapy.

Xu C, Yuan X, Hou P, Li Z, Wang C, Fang C Cancer Biol Med. 2023; 20(5).

PMID: 37283493 PMC: 10246443. DOI: 10.20892/j.issn.2095-3941.2023.0061.


Utility of the Cerebral Organoid Glioma 'GLICO' Model for Screening Applications.

Weth F, Peng L, Paterson E, Tan S, Gray C Cells. 2023; 12(1).

PMID: 36611949 PMC: 9818141. DOI: 10.3390/cells12010153.


References
1.
Pasca A, Sloan S, Clarke L, Tian Y, Makinson C, Huber N . Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat Methods. 2015; 12(7):671-8. PMC: 4489980. DOI: 10.1038/nmeth.3415. View

2.
Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin N . Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. 2006; 9(5):391-403. DOI: 10.1016/j.ccr.2006.03.030. View

3.
Verhaak R, Hoadley K, Purdom E, Wang V, Qi Y, Wilkerson M . Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010; 17(1):98-110. PMC: 2818769. DOI: 10.1016/j.ccr.2009.12.020. View

4.
Singh S, Clarke I, Terasaki M, Bonn V, Hawkins C, Squire J . Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63(18):5821-8. View

5.
Kadoshima T, Sakaguchi H, Nakano T, Soen M, Ando S, Eiraku M . Self-organization of axial polarity, inside-out layer pattern, and species-specific progenitor dynamics in human ES cell-derived neocortex. Proc Natl Acad Sci U S A. 2013; 110(50):20284-9. PMC: 3864329. DOI: 10.1073/pnas.1315710110. View